Register entry
E.R. Squibb & Sons, L.L.C.
- Registered sites
- 0
- Drug products
- 49
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
49Showing 49 of 49.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AZACTAM | AZTREONAM | INJECTION, POWDER, FOR SOLUTION | NDA |
| AZACTAM | AZTREONAM | INJECTION, POWDER, FOR SOLUTION | NDA |
| Augtyro | repotrectinib | CAPSULE | NDA |
| Augtyro | repotrectinib | CAPSULE | NDA |
| BARACLUDE | entecavir | TABLET, FILM COATED | NDA |
| BARACLUDE | entecavir | TABLET, FILM COATED | NDA |
| BARACLUDE | entecavir | SOLUTION | NDA |
| Cobenfy | xanomeline and trospium chloride | CAPSULE, COATED PELLETS | NDA |
| Cobenfy | xanomeline and trospium chloride | CAPSULE, COATED PELLETS | NDA |
| Cobenfy | xanomeline and trospium chloride | CAPSULE, COATED PELLETS | NDA |
| Cobenfy | xanomeline and trospium chloride | KIT | NDA |
| Cobenfy | xanomeline and trospium chloride | KIT | NDA |
| ELIQUIS | apixaban | TABLET, FILM COATED | NDA |
| ELIQUIS | apixaban | TABLET, FILM COATED | NDA |
| ELIQUIS | apixaban | TABLET, FOR SUSPENSION | NDA |
| ELIQUIS 30-Day Starter Pack | apixaban | KIT | NDA |
| ELIQUIS 30-Day Starter Pack | apixaban | KIT | NDA |
| ELIQUIS SPRINKLE | apixaban | CAPSULE | NDA |
| EMPLICITI | elotuzumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| EMPLICITI | elotuzumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| EVOTAZ | atazanavir and cobicistat | TABLET | NDA |
| HALOG | Halcinonide | SOLUTION | NDA |
| KENALOG-10 | TRIAMCINOLONE ACETONIDE | INJECTION, SUSPENSION | NDA |
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | INJECTION, SUSPENSION | NDA |
| KENALOG-80 | TRIAMCINOLONE ACETONIDE | INJECTION, SUSPENSION | NDA |
| NULOJIX | BELATACEPT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| OPDIVO | nivolumab | INJECTION | BLA |
| OPDIVO | nivolumab | INJECTION | BLA |
| OPDIVO | nivolumab | INJECTION | BLA |
| OPDIVO | nivolumab | INJECTION | BLA |
| OPDIVO QVANTIG | nivolumab and hyaluronidase-nvhy | INJECTION, SOLUTION | BLA |
| OPDIVO QVANTIG | nivolumab and hyaluronidase-nvhy | INJECTION, SOLUTION | BLA |
| OPDUALAG | nivolumab and relatlimab-rmbw | INJECTION | BLA |
| ORENCIA | abatacept | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| ORENCIA | abatacept | INJECTION, SOLUTION | BLA |
| ORENCIA | abatacept | INJECTION, SOLUTION | BLA |
| ORENCIA | abatacept | INJECTION, SOLUTION | BLA |
| REYATAZ | ATAZANAVIR | CAPSULE, GELATIN COATED | NDA |
| REYATAZ | ATAZANAVIR | CAPSULE, GELATIN COATED | NDA |
| REYATAZ | ATAZANAVIR | POWDER | NDA |
| SOTYKTU | deucravacitinib | TABLET, FILM COATED | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| SPRYCEL | dasatinib | TABLET | NDA |
| YERVOY | ipilimumab | INJECTION | BLA |
| YERVOY | ipilimumab | INJECTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.